Literature DB >> 10680000

Cytology of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

A H Deshpande1, S Nayak, M M Munshi.   

Abstract

Sinus histiocytosis with massive lymphadenopathy (SHML) is a benign, self-limiting condition of unknown etiology, which generally presents as massive bilateral cervical lymphadenopathy. It is important to distinguish SHML from other causes of histiocytosis because of the different treatment modalities. This study was carried out to assess the utility of fine-needle aspiration cytology (FNAC) findings in SHML and to distinguish if from other reactive lymphadenopathies. The lymph nodes in 4 patients (3 male and 1 female) presenting with massive bilateral cervical lymphadenopathy were aspirated. All presented with persistent bilateral cervical lymphadenopathy, polymorphnuclear leukocytosis, and raised erythrocyte sedimentation rate (ESR). Smears showed a reactive lymphoid population consisting of mature lymphocytes, plasma cells, a few polymorphs, and many histiocytes showing emperipolesis. Based on the cytologic and clinical findings, a diagnosis of SHML was made. Histopathology confirmed the diagnosis in all cases. A conclusive diagnosis of SHML can be based on cytology, provided that the cytologic findings are interpreted in the appropriate clinical context. Biopsy can be avoided in these patients. Diagn. Cytopathol. 2000;22:181-185. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10680000     DOI: 10.1002/(sici)1097-0339(20000301)22:3<181::aid-dc10>3.0.co;2-6

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  13 in total

1.  Diagnosis of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease) by fine needle aspiration cytology.

Authors:  Rashmi Kushwaha; Charanjeet Ahluwalia; Varuna Sipayya
Journal:  J Cytol       Date:  2009-04       Impact factor: 1.000

2.  Fine needle aspiration diagnosis of Rosai-Dorfman Disease involving thyroid.

Authors:  Sudhir Kumar Vujhini; Sachin S Kolte; Rahul N Satarkar; Shastry Srikanth
Journal:  J Cytol       Date:  2012-01       Impact factor: 1.000

3.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease): A case report and review of 49 cases with fine needle aspiration cytology.

Authors:  Yuquan Shi; Adrienne Carruth Griffin; Paul Jl Zhang; James N Palmer; Prabodh Gupta
Journal:  Cytojournal       Date:  2011-02-12       Impact factor: 2.091

4.  Anterior abdominal wall Rosai-Dorfman disease diagnosed by fine-needle aspiration cytology.

Authors:  Preethi S Chari; Jayaram Iyengar
Journal:  J Cytol       Date:  2015 Jul-Sep       Impact factor: 1.000

5.  Cytodiagnosis of Rosai-Dorfman disease masquerading as lymphoma: A case report with brief review of literature.

Authors:  Manjari Kishore; Prajwala Gupta; Arvind Ahuja; Minakshi Bhardwaj
Journal:  J Lab Physicians       Date:  2018 Oct-Dec

6.  Diagnosis of rosai-dorfman disease in elderly female on fine needle aspiration cytology: a case report.

Authors:  Meher Aziz; Prasenjit Sen Ray; Nazima Haider; Sumit Prakash Rathore
Journal:  Case Rep Pathol       Date:  2012-10-14

Review 7.  Modeling cell-in-cell structure into its biological significance.

Authors:  M-f He; S Wang; Y Wang; X-n Wang
Journal:  Cell Death Dis       Date:  2013-05-16       Impact factor: 8.469

8.  Prevalence of heterotypic tumor/immune cell-in-cell structure in vitro and in vivo leading to formation of aneuploidy.

Authors:  Yu-hui Chen; Shan Wang; Mei-fang He; Yanyi Wang; Hua Zhao; Han-yu Zhu; Xiao-min Yu; Jian Ma; Xiao-juan Che; Ju-fang Wang; Ying Wang; Xiao-ning Wang
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

9.  Intracranial ROSAI-DORFMAN Disease.

Authors:  Parvin Mahzoni; Mohsen Hani Tabaei Zavareh; Marzie Bagheri; Neda Hani; Babak Moqtader
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

10.  Rosai dorfman disease of the orbit.

Authors:  Geeta K Vemuganti; Milind N Naik; Santosh G Honavar
Journal:  J Hematol Oncol       Date:  2008-06-28       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.